Guidelines for the diagnosis and treatment of pulmonary hypertension, Revista Portuguesa de Cardiologia (English Edition), vol.31, issue.1, pp.1219-63, 2009. ,
DOI : 10.1016/j.repce.2011.10.006
Guidelines for the diagnosis and treatment of pulmonary hypertension, ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT), pp.2493-537, 2009. ,
DOI : 10.1016/j.repce.2011.10.006
Treatment of Pulmonary Arterial Hypertension, New England Journal of Medicine, vol.351, issue.14, pp.1425-1461, 2004. ,
DOI : 10.1056/NEJMra040291
URL : https://hal.archives-ouvertes.fr/hal-01455600
Mutation, American Journal of Respiratory and Critical Care Medicine, vol.177, issue.12, pp.1377-83, 2008. ,
DOI : 10.1164/rccm.200712-1807OC
URL : https://hal.archives-ouvertes.fr/inserm-00668454
Clinical Implications of Determining BMPR2 Mutation Status in a Large Cohort of Children and Adults With Pulmonary Arterial Hypertension, The Journal of Heart and Lung Transplantation, vol.27, issue.6, pp.668-74, 2008. ,
DOI : 10.1016/j.healun.2008.02.009
Clinical Outcomes of Pulmonary Arterial Hypertension in Patients Carrying an ACVRL1 (ALK1) Mutation, Am J Respir Crit Care Med, issue.8, pp.181851-61, 2010. ,
Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic Telangiectasia, New England Journal of Medicine, vol.345, issue.5, pp.325-359, 2001. ,
DOI : 10.1056/NEJM200108023450503
Transforming Growth Factor-?? Receptor Mutations and Pulmonary Arterial Hypertension in Childhood, Circulation, vol.111, issue.4, pp.435-476, 2005. ,
DOI : 10.1161/01.CIR.0000153798.78540.87
Endoglin germline mutation in a patient with hereditary haemorrhagic telangiectasia and dexfenfluramine associated pulmonary arterial hypertension, Thorax, vol.59, issue.5, pp.446-454, 2004. ,
DOI : 10.1136/thx.2003.11890
Truncating and missense BMPR2 mutations differentially affect the severity of heritable pulmonary arterial hypertension, Respiratory Research, vol.111, issue.23, p.87, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.104.488486
Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension, Chest, vol.126, issue.1, pp.14-34, 2004. ,
DOI : 10.1378/chest.126.1_suppl.14S
Pulmonary Arterial Hypertension in France, American Journal of Respiratory and Critical Care Medicine, vol.173, issue.9, pp.1023-1053, 2006. ,
DOI : 10.1164/rccm.200510-1668OC
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension, Circulation, vol.111, issue.23, pp.3105-3116, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.104.488486
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension, Journal of the American College of Cardiology, vol.40, issue.4, pp.780-788, 2002. ,
DOI : 10.1016/S0735-1097(02)02012-0
Survival in patients with idiopathic, familial, and anorexigenassociated pulmonary arterial hypertension in the modern management era, Am J Respir Crit Care Med, vol.181, p.4812, 2010. ,
Gene expression in BMPR2 mutation carriers with and without evidence of Pulmonary Arterial Hypertension suggests pathways relevant to disease penetrance, BMC Medical Genomics, vol.3, issue.3, p.45, 2008. ,
DOI : 10.1016/0960-7404(94)90047-7
Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females, European Respiratory Journal, vol.34, issue.5, pp.1093-1102, 2009. ,
DOI : 10.1183/09031936.00010409
Applying nonsense-mediated mRNA decay research to the clinic: progress and challenges, Trends in Molecular Medicine, vol.12, issue.7, pp.306-322, 2006. ,
DOI : 10.1016/j.molmed.2006.05.005
The position of premature termination codons in the hepatocyte nuclear factor ???1 beta gene determines susceptibility to nonsense-mediated decay, Human Genetics, vol.18, issue.9, pp.214-238, 2005. ,
DOI : 10.1007/s00439-005-0023-y
allele, Human Mutation, vol.91, issue.4, pp.649-54, 2009. ,
DOI : 10.1002/humu.20922
Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension, Human Molecular Genetics, vol.11, issue.13, pp.1517-1542, 2002. ,
DOI : 10.1093/hmg/11.13.1517
Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension, Human Molecular Genetics, vol.17, issue.11, pp.1683-94, 2008. ,
DOI : 10.1093/hmg/ddn059
Absence of influence of gender and BMPR2 mutation type on clinical phenotypes of pulmonary arterial hypertension Respiratory Research, p.73, 2010. ,